Surmodics | SRDX - Чистый доход





Чистый доход Изменить Дата
Abbott USD 1.78B 132M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Artivion USD 2.42M 4.07M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Boston Scientific USD 672M 83M 2025-12
EDAP TMS EUR -5.01M 586K 2025-09
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
J&J USD 5.12B 36M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Mesa Laboratories USD -1.68M 5.1M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Option Care Health USD 58.5M 6.69M 2025-12
Stryker USD 849M 10M 2025-12
Surmodics USD -5.32M 6.22M 2025-06
Trinity Biotech USD -5.14M 11.82M 2025-09